| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-02-27 | Thomas Stephen Basil Director | Sale | -50,000 | -24.43%154,657 | $7.01 | $350,253 | View SEC filing | |
| 2026-02-17 | Thomas Stephen Basil Director | Sale | -100,000 | -32.82%204,657 | $5.29 | $529,129 | View SEC filing | |
| 2026-01-07 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +7,111 | +0.21%3,403,429 | $3.50 | $24,889 | View SEC filing | |
| 2025-12-15 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +314,561 | +10.21%3,396,318 | $2.40 | $754,737 | View SEC filing | |
| 2025-07-01 | Brennan Aoife President and CEO | Sale | -20,618 | -29.99%48,132 | $1.22 | $25,154 | View SEC filing | |
| 2025-06-20 | Pimblett Emily SVP, Finance & CAO | Sale | -1,242 | -6.17%18,888 | $1.24 | $1,540 | View SEC filing | |
| 2025-03-20 | Pimblett Emily SVP, Finance & CAO | Sale | -1,199 | -7.34%15,130 | $1.31 | $1,571 | View SEC filing | |
| 2024-12-20 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale | -1,235 | -9.83%11,329 | $2.02 | $2,495 | View SEC filing | |
| 2024-09-20 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale | -1,191 | -13.60%7,564 | $8.18 | $9,741 | View SEC filing | |
| 2024-07-23 | Morisset Valerie EVP, R&D AND CSO | Sale | -129,206 | -80.49%31,317 | $7.65 | $988,495 | View SEC filing | |
| 2024-07-19 | Morisset Valerie EVP, R&D AND CSO | Sale | -41,783 | -20.65%160,523 | $6.93 | $289,492 | View SEC filing | |
| 2024-07-17 | Morisset Valerie EVP, R&D AND CSO | Sale | -50,000 | -19.82%202,306 | $7.13 | $356,500 | View SEC filing | |
| 2024-07-16 | Morisset Valerie EVP, R&D AND CSO | Sale | -92,377 | -26.80%252,306 | $7.04 | $650,563 | View SEC filing | |
| 2024-07-11 | Morisset Valerie EVP, R&D AND CSO | Sale | -105,931 | -23.51%344,683 | $6.95 | $736,500 | View SEC filing | |
| 2024-07-09 | Morisset Valerie EVP, R&D AND CSO | Sale | -12,342 | -2.67%450,614 | $7.06 | $87,135 | View SEC filing | |
| 2024-07-03 | Morisset Valerie EVP, R&D AND CSO | Sale | -50,000 | -9.75%462,956 | $6.76 | $338,000 | View SEC filing | |
| 2024-07-01 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +13,008,546 | -75.23%2,866,375 | $3.84 | $49,952,817 | View SEC filing | |
| 2024-06-21 | Pimblett Emily CHIEF ACCOUNTING OFFICER | Sale | -1,245 | -24.90%3,755 | $7.21 | $8,982 | View SEC filing | |
| 2021-08-16 | Blavatnik Len Other | Purchase | +800,000 | +19.01%5,009,400 | $12.50 | $10,000,000 | View SEC filing | |
| 2021-08-16 | RA Capital Healthcare Fund LP Director, 10% Owner | Purchase | +3,200,000 | -93.63%483,679 | $12.50 | $40,000,000 | View SEC filing |
1-20 of 20
